Adjuvant EBRT improves survival in patients with lymph-node-negative pancreatic cancer.
Hazard
Lisa J
LJ
Department of Radiation Oncology, Huntsman Cancer Hospital, University of Utah School of Medicine, Salt Lake City, UT 84112-5560, USA. lisa.hazard@hci.utah.edu
Tward
Jonathan D
JD
Shrieve
Dennis C
DC